The use of live recombinant Salmonella attenuated vaccine (RASV) encoding Yersinia proteins is a promising new approach for the vaccination against Yersinia pestis. We have tested the efficacy of 2 proteins, Psn and a portion of LcrV in protecting mice against virulent Yersinia pestis challenge. To remove the immunosuppressive properties of LcrV protein, the lcrV gene, without the TLR2 receptor sequence, was cloned into a beta-lactamase secretion vector. Immunizations were performed with RSAV expressing LcrV or Psn. Challenge with a virulent Y. pestis strain was performed 4 weeks after the last immunization. Our results show that the truncated LcrV protein delivered by RASV is sufficient to afford a full protective immune response in a mouse model of bubonic plague and the Psn protein afforded partial protection in a non-optimized system. This finding should facilitate the design and development of a new generation of vaccines against Y. pestis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/978-0-387-72124-8_36 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Genomic characteristics and virulence of common but overlooked Yersinia intermedia, Y. frederiksenii, and Y. kristensenii in food.
Int J Food Microbiol
January 2025
College of Food Science and Engineering, Northwest A&F University, Yangling, Shaanxi 712100, China. Electronic address:
Article Synopsis
- Three species of Yersinia (Y. intermedia, Y. frederiksenii, and Y. kristensenii), common foodborne pathogens, were analyzed using genomic data to uncover their potential threat, revealing significant genomic diversity and a noteworthy presence in Europe and Asia.
- Y. intermedia demonstrated a high level of accessory genes, suggesting adaptability and the ability to acquire beneficial traits, while all three species contained various mobile genetic elements including plasmids and insertion sequences.
- Differences in antibiotic resistance genes and virulence gene composition were noted, with Y. kristensenii being the most virulent, containing the most virulence genes, while Y. frederiksenii showed unique pathogenic mechanisms.
Contribution of Teeth to Confirm Diagnosis of Plague in Marseille, France (1720-1722).
J Hist Dent
January 2025
Ecole de Médecine Dentaire de Marseille, 27 boulevard Jean Moulin 13385 Marseille Aix-Marseille Université, CNRS, EFS, ADES, Marseille, France.
Plague is an infectious disease caused by a Gram-negative bacterium, , and has affected human populations in different pandemics for at least 5000 years. The last plague epidemic in France occurred at the beginning of eighteenth century in Marseille, in southeast France. Marseille is today France's second largest city.
View Article and Find Full Text PDFElucidation of peptide screen for targeted identification of Yersinia pestis by nano-liquid chromatography tandem mass spectrometry.
Sci Rep
January 2025
Microbiology Division, Defence Research and Developmental Establishment, Jhansi Road, Gwalior, 474002, India.
Yersinia pestis, a Gram-negative bacterium is the causative agent of the fatal communicable disease plague. The disease had a profound impact on human history. Plague bacteria are usually transmitted to humans through the bite of an infected rat flea.
View Article and Find Full Text PDFThe Protective Effect of IL-17A in Pneumonic Plague Can Be Compensated by Effective Vaccines and Immunization Strategies in Mice.
Vaccines (Basel)
December 2024
Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Plague, caused by , poses a public health threat not only due to sporadic outbreaks across the globe but also due to its potential as a biothreat agent. Ironically, among the seven deadliest pandemics in global history, three were caused by . Pneumonic plague, the more contagious and severe form of the disease, is difficult to contain, requiring either prophylactic antibiotic treatment or vaccination.
View Article and Find Full Text PDFDevelopment of Effective Medical Countermeasures Against the Main Biowarfare Agents: The Importance of Antibodies.
Microorganisms
December 2024
Targeted Therapy Team, Institute for Cancer Research, 237 Fulham Road, London SW3 6JB, UK.
The COVID-19 and mpox crisis has reminded the world of the potentially catastrophic consequences of biological agents. Aside from the natural risk, biological agents can also be weaponized or used for bioterrorism. Dissemination in a population or among livestock could be used to destabilize a nation by creating a climate of terror, by negatively impacting the economy and undermining institutions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!